Literature DB >> 9285554

Mdm2: keeping p53 under control.

J Piette1, H Neel, V Maréchal.   

Abstract

The Mdm2 gene is overexpressed in several human tumors. The oncogenic potential of Mdm2 is partially explained by the inhibition of the activity of the tumor suppressor protein p53. Determination of the three-dimensional structure of complexes between Mdm2 and the N-terminal p53 peptide provided a molecular basis for the inhibition of the transcriptional function of p53 by Mdm2. More dramatically, p53 is targeted by Mdm2 for rapid degradation. The Mdm2 gene itself is activated by p53, which gives the opportunity for feed-back control of p53 activity. Keeping p53 under control is most likely the major task of Mdm2 during early development. Recently, evidence was provided for an alternative, p53-independent function of Mdm2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285554     DOI: 10.1038/sj.onc.1201432

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 3.  Viruses and apoptosis.

Authors:  B J Thomson
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

4.  MDM2/p53 protein expression in the development of colorectal adenocarcinoma.

Authors:  G Abdel-Fattah; B Yoffe; B Krishnan; V Khaoustov; K Itani
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

5.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Regulated degradation is a mechanism for suppressing stochastic fluctuations in gene regulatory networks.

Authors:  Hana El-Samad; Mustafa Khammash
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

7.  Elucidating the digital control mechanism for DNA damage repair with the p53-Mdm2 system: single cell data analysis and ensemble modelling.

Authors:  Babatunde A Ogunnaike
Journal:  J R Soc Interface       Date:  2006-02-22       Impact factor: 4.118

8.  Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.

Authors:  Sunil K Manna; Julie S Bose; Vijay Gangan; Nune Raviprakash; Thota Navaneetha; Pongali B Raghavendra; Banaganapalli Babajan; Chitta S Kumar; Swatantra K Jain
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

9.  p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.

Authors:  Berthold Gerdes; Annette Ramaswamy; Andreas Ziegler; Sven A Lang; Michael Kersting; Renate Baumann; Anja Wild; Roland Moll; Matthias Rothmund; Detlef K Bartsch
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

10.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.